Story posted today so getting so e expanded coverage. Short excerpt below
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition.
They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis” by Wang, et al.
Re: "Story posted today so getting so e expanded coverage."
Today, nobeach? I posted this story here last Thursday.
Sentiment: Strong Buy
The copy didn't come through. Story is posted TODAY on knoefpler's website.
Theres, eventhough that news may be old, it's good to see you posting something relevant, thanks.